Cashu | News | TAK

HomeWatchlistNewsSignalsPicks

DJI

-0.55%

SPX

-0.69%

IXIC

-0.82%

FTSE

+0.52%

N225

-0.88%

AXJO

-1.82%

HomeWatchlistNewsSignalsPicks

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Privacy Policy
Terms of Use

Instagram YouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Latest Takeda Pharmaceutical Company News

What's Going On With Takeda Stock On Friday?

Feature Image for interests on Biotech, Health Care, Healthcare, Large Cap from benzinga.com

Ionis Pharma Wins FDA Nod For First RNA-Targeted Therapy For Rare Genetic Swelling Disorder

Feature Image for interests on Biotech, Health Care, Healthcare, Large Cap from benzinga.com

Takeda Pharma Maintains Outlook Even As Vyvanse Generics Hit Sales

Feature Image for interests on Biotech, Earnings, Healthcare, Large Cap from benzinga.com

about 1 month ago

Trump's pharmaceutical tariffs could affect some drugmakers more than others

Feature Image for interests on Biotech And Pharmaceuticals, Biotechnology, Breaking News: Business, Business from cnbc.com

about 1 month ago

Insights Ahead: Takeda Pharmaceutical's Quarterly Earnings

about 1 month ago

Wisner Baum: Ninth Circuit Affirms Actos RICO Class Action Certification Against Takeda and Eli Lilly

Feature Image for interests on Health Care & Hospitals, Healthcare, Legal Issues, Stock from prnewswire.com

Keros Therapeutics' Quiet Near-Term Outlook Overshadows Pipeline Potential: Analyst

Feature Image for interests on Analyst Color, Briefs, Equities, Expert Ideas from benzinga.com

Japanese Pharma Company Takeda Expects Limited Exposure To US-China Tariffs

Feature Image for interests on Benzinga, Biotech, Briefs, China from benzinga.com

Novavax Announces Significantly Improved Terms for Collaboration and License Agreement with Takeda for Nuvaxovid in Japan

Feature Image for interests on Computer & Electronics, Healthcare, Infection Control, Japan from prnewswire.com

Belief BioMed and Takeda China jointly announced BBM-H901 (Dalnacogene Ponparvovec Injection), China's first hemophilia B gene therapy, was officially approved

Stocks

Health Care

tak

Takeda Pharmaceutical Company

TOKYO STOCK EXCHANGE-TOKYO PRO MARKET: TAK

+0.17 (+1.13%)

15.16

USD

At close at Sep 02, 20:38 UTC

Latest Cashu News

Takeda Pharmaceutical: Navigating Market Volatility and Strategic Innovation in Pharmaceuticals

Takeda Pharmaceutical's Commitment to Innovative Treatments for Hereditary Angioedema with IONS Dawnzera

Takeda Pharmaceutical's Role in Advancing Treatment for Hereditary Angioedema with IONS Dawnzera Approval